Novel extended quadruplet induction regimens—challenging the need for upfront high-dose therapy in newly diagnosed all-risk multiple myeloma patients

Klaus Podar

Novel extended quadruplet induction regimens—challenging the need for upfront high-dose therapy in newly diagnosed all-risk multiple myeloma patients

Klaus Podar

Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Übersichtsartikel

Originalsprache	Englisch
Fachzeitschrift	AME Clinical Trials Review
Publikationsstatus	Veröffentlicht - 07 Apr. 2025

Zugriff auf Dokument

https://actr.amegroups.org/issue/publishAheadOfPrint.

Andere Dateien und Links

ACTR-24-191-final

Dieses zitieren

@article{171ad9a18fcf4d6ea81bd25e487c67be,

title = "Novel extended quadruplet induction regimens—challenging the need for upfront high-dose therapy in newly diagnosed all-risk multiple myeloma patients",

author = "Klaus Podar",

year = "2025",

month = apr,

day = "7",

language = "English",

journal = "AME Clinical Trials Review ",

issn = "3005-6152",

}